DANIEL LEMBO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LANCASTER, PA NPI 1497463152
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PA Acerta Pharma LLC All categories
General Payments — all program years on this page
$161.05
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $161.05 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $161.05 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $52.94 | 3 |
| Astellas Pharma US Inc | $28.08 | 1 |
| Novo Nordisk AS | $26.09 | 1 |
| PFIZER INC. | $22.20 | 1 |
| SCPHARMACEUTICALS INC. | $15.96 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.78 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $161.05 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086297238 | Bayer Healthcare Pharmaceuticals Inc. | $15.78 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100281266 | Novo Nordisk Inc | $26.09 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104461574 | AstraZeneca Pharmaceuticals LP | $14.41 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104532158 | AstraZeneca Pharmaceuticals LP | $19.15 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105846179 | AstraZeneca Pharmaceuticals LP | $19.38 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131211303 | PFIZER INC. | $22.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132316200 | SCPHARMACEUTICALS INC. | $15.96 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139555143 | Astellas Pharma US Inc | $28.08 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.